PRSS12
protein-codingserine protease 12, the group of Scavenger receptor cysteine rich domain containing|Serine proteases
Gene summary
This gene encodes a member of the trypsin family of serine proteases and contains a signal peptide, a proline-rich region, a Kringle domain, four scavenger receptor cysteine-rich domains, and a trypsin-like serine protease domain. The protein, sometimes referred to as neurotrypsin or motopsin, is secreted from neuronal cells and localizes to the synaptic cleft. Studies in mice show that this protein cleaves a protein, agrin, that is important for the formation and maintenance of exitatory synapses. Defects in this gene cause a form of autosomal recessive cognitive impairment (MRT1). [provided by RefSeq, Jul 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~73.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0000509
Submitter: Illumina
Inheritance Pattern: AR
Disease ID:MONDO:0009580
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0000509
Submitter: ClinGen
*PRSS12* is located at chromosome 4q26 and encodes a synaptic serine protease expressed in the brain. *PRSS12* was first reported in relation to non-syndromic intellectual disability in 2002 (Molinari et al., PMID: 12459588) in two consanguineous families. Only one proband with a homozygous frameshift variant was scored. A second proband also carried the same homozygous frameshift variant, but both families originated from the same region of Eastern Algeria and were found to carry the variant on the same haplotype, so this individual was not scored. Segregation data was scored in Family 1, in which the variant was identified in a homozygous state in four affected siblings and in a heterozygous state in three unaffected siblings (PMID: 12459588). *Prss12* knockout mice showed no deficits in long-term memory, but had altered social interaction compared to wild-type mice (PMID: 20092579). In addition, knockout mice had reduced hippocampal apical spine density, reduced phosphorylated CREB expression after behavioral stimulation, and reduced activity-dependent formation of dendritic filopodia in the hippocampus (PMIDs: 19303856, 20092579). The evidence from knockout mouse models was not scored as there is very limited genetic data, so the implication for a human phenotype is currently unclear. In summary, there is limited evidence to support the relationship between *PRSS12* and non-syndromic intellectual disability. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This gene-disease pair was originally evaluated by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on August 4, 2021. It was reevaluated on August 21, 2026. As a result of this reevaluation, no additional patients were identified and the classification did not change. The scoring was updated to be consistent with SOP Version 12.
Inheritance Pattern: AR
Disease ID:MONDO:0009580
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0019502
Submitter: Orphanet
Inheritance Pattern: Unknown
Disease ID:MONDO:0009580
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PRSS12 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003619.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 11 | 27 | 2 | 40 | ||
| missense | 188 | 10 | 198 | |||
| nonsense | 2 | 9 | 11 | |||
| start loss | 0 | |||||
| frameshift | 3 | 9 | 1 | 13 | ||
| splice donor/acceptor (+/-2bp) | 1 | 5 | 6 | |||
| Total | 0 | 6 | 222 | 38 | 2 | 268 |
Highest pathogenic variant AF is 0.000039653773
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003610.2 | 13 | MANE Select | |
| Ensembl | ENSP00000296498.3 | 13 | MANE Select | |
| RefSeq | NP_001427478.1 | 13 | Standard | |
| RefSeq | NP_001427479.1 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- exocytosis
- receptor-mediated endocytosis
- zymogen activation
Molecular Function
- serine-type endopeptidase activity
- scavenger receptor activity
- serine-type peptidase activity
Cellular Component
- plasma membrane
- axon
- dendrite
- cytoplasmic vesicle
- synaptic cleft
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000296498
- Coding exons
- 13
- Length
- 72966
- Individuals with no LoFs
- 125006
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 740
- Defined
- 125748
- p
- 0.00295
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.387 | 460 | 484 | 0.951 | 0.0000260 | 5628 |
| Missense (PolyPhen) | 165 | 175.14 | 0.94208 | 2074 | ||
| Synonymous | 0.402 | 175 | 182 | 0.962 | 0.00000952 | 1727 |
| Loss of Function | 0.221 | 44 | 45.6 | 0.965 | 0.00000249 | 503 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0012 | 0.0012 | notable |
| Latino/Admixed American | 0.0024 | 0.0024 | notable |
| Ashkenazi Jewish | 0.0026 | 0.0026 | notable |
| East Asian | 0.0023 | 0.0023 | notable |
| Finnish | 0.0099 | 0.0098 | notable |
| European (Non-Finnish) | 0.0018 | 0.0017 | notable |
| South Asian | 0.0050 | 0.0050 | notable |
| Other | 0.0016 | 0.0016 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays a role in neuronal plasticity and the proteolytic action may subserve structural reorganizations associated with learning and memory operations. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.136
Intolerance Scores
- LoFtool
- 0.310
- RVIS EVS
- 0.07
- RVIS percentile EVS
- 59.16
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.247
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |